Evaluation of Pancreatic Exocrine Secretion Using 13C-Dipeptide (Benzoyl-L-Tyrosyl-[1-13C]Alanine) Breath Test

Authors:
  • TKTadashi Kohno
    Tadashi Kohno
  • AIAsuka Ito
    Asuka Ito
  • SSShigeru Suzuki
    Shigeru Suzuki
  • TKTomohisa Kohno
    Tomohisa Kohno
  • TTTadatoshi Takayama
    Tadatoshi Takayama
  • SASatoshi Asai
    Satoshi Asai

Abstract
We investigated whether a breath test using benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala) allows assessment of pancreatic exocrine function. Benzoyl-L-tyrosyl-[1-13C]alanine was orally administered, and changes in 13CO2 were expressed as Δ‰. The breath test was performed in chronic pancreatitis patients and healthy subjects in a preliminary study and, subsequently, in 17 pancreatoduodenectomy patients, to examine the difference between the results obtained at the times of pancreatic tube insertion and removal, the relationship between breath test results after tube removal and the volume of pancreatic juice drained, and the difference in results between the presence versus the absence of histological changes of chronic pancreatitis. The Δ‰ was lower in the chronic pancreatitis patients than in healthy subjects. In the postoperative patients, the Δ‰ was higher at tube insertion than at tube removal. The correlations of the Δ‰ with the maximum volume of pancreatic juice, its mean volume, and pancreatic juice amylase levels were 0.865, 0.757, and 0.853, respectively. The Δ‰ was lower in 11 patients with that in 6 patients without histological changes of chronic pancreatitis. These results suggest that the Bz-Tyr-Ala breath test can measure pancreatic exocrine function.

This publication has 14 references indexed in Scilit: